MSC therapy is clinically validated in over 40 randomised controlled trials across lupus, rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. Published in Stem Cell Research & Therapy and peer-reviewed journals worldwide.
Autoimmune diseases occur when the immune system mistakenly attacks healthy tissues. Conventional treatment focuses on broad immunosuppression, calming the attack but leaving the underlying dysregulation untouched.
Mesenchymal stem cells (MSCs) are immunomodulatory, not immunosuppressive. They help restore balance to overactive immune responses, supporting regulatory T cell function and calming chronic inflammation at its source.
A chronic condition where the immune system produces antibodies against the body's own tissues, affecting skin, joints, kidneys, and other organs. Multiple clinical trials have shown MSC transplantation can support refractory SLE cases, including lupus nephritis, with documented safety across long-term follow-up studies.
A systemic autoimmune disorder that inflames the synovial membrane, causing chronic joint pain, cartilage damage, and progressive disability. MSCs have demonstrated both immunomodulatory and tissue-repairing properties in RA, targeting T cell proliferation and inflammatory cytokines whilst supporting cartilage regeneration.
A neurological autoimmune condition where the immune system damages the myelin sheath protecting nerve fibres, disrupting communication between brain and body. MSC therapy supports immune modulation and has shown potential in promoting endogenous repair in clinical and preclinical studies.
Includes Crohn's disease and ulcerative colitis, where chronic immune-driven inflammation damages the gastrointestinal tract. MSC therapy supports tissue regeneration whilst suppressing inappropriate immune activity, and is particularly studied for complex perianal fistulas and refractory cases.
We review cases for ankylosing spondylitis, primary Sjögren's syndrome, systemic sclerosis, psoriasis, and related immune-mediated disorders. Each condition is assessed individually against the current scientific evidence before we advise whether cell therapy is appropriate for you.
Mesenchymal stem cells are delivered via IV infusion. This is the clinically validated delivery method used in the majority of published autoimmune disease trials, allowing cells to circulate and home to sites of active inflammation.
Where conventional treatment broadly suppresses immune function, MSCs modulate it. They encourage regulatory T cell proliferation, calm inflammatory cytokines, and reduce B cell overactivity without compromising healthy immunity.
Every protocol is tailored to the specific autoimmune condition, disease activity level, and prior treatment history. Dosing, frequency, and complementary care are designed around your individual case profile.
The following improvements have been reported by past patients. Results vary by individual, improvements cannot be guaranteed.
Years of immunosuppressants and steroids may calm the symptoms, but they rarely address the underlying dysregulation. Share your diagnosis, medication history, and recent bloodwork. Our medical team will assess whether cell therapy is a fit for your condition.
Request a Case Review